![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | GALNT17 | Human | 2,2',4,4',5,5'-hexachlorobiphenyl | multiple interactions | ISO | Galnt17 (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | GALNT17 | Human | 2,2',5,5'-tetrachlorobiphenyl | multiple interactions | ISO | Galnt17 (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | GALNT17 | Human | 2,4-dibromophenyl 2,4,5-tribromophenyl ether | affects expression | ISO | Galnt17 (Mus musculus) | 6480464 | 2 more ... | CTD | PMID:38648751 | GALNT17 | Human | 2-palmitoylglycerol | increases expression | EXP | | 6480464 | 2-palmitoylglycerol results in increased expression of GALNT17 mRNA | CTD | PMID:37199045 | GALNT17 | Human | 4,4'-sulfonyldiphenol | increases methylation | ISO | Galnt17 (Mus musculus) | 6480464 | bisphenol S results in increased methylation of GALNT17 exon | CTD | PMID:33297965 | GALNT17 | Human | aflatoxin B1 | increases methylation | EXP | | 6480464 | Aflatoxin B1 results in increased methylation of WBSCR17 intron | CTD | PMID:30157460 | GALNT17 | Human | amiodarone | increases expression | EXP | | 6480464 | Amiodarone results in increased expression of GALNT17 mRNA | CTD | PMID:19774075 | GALNT17 | Human | antirheumatic drug | increases expression | EXP | | 6480464 | Antirheumatic Agents results in increased expression of GALNT17 mRNA | CTD | PMID:24449571 | GALNT17 | Human | arsane | affects methylation | EXP | | 6480464 | Arsenic affects the methylation of GALNT17 gene | CTD | PMID:25304211 | GALNT17 | Human | arsenic atom | affects methylation | EXP | | 6480464 | Arsenic affects the methylation of GALNT17 gene | CTD | PMID:25304211 | GALNT17 | Human | arsenite(3-) | increases methylation | EXP | | 6480464 | arsenite results in increased methylation of GALNT17 promoter | CTD | PMID:23974009 | GALNT17 | Human | atrazine | affects methylation | ISO | Galnt17 (Rattus norvegicus) | 6480464 | Atrazine affects the methylation of GALNT17 gene and Atrazine affects the methylation of WBSCR17 gene | CTD | PMID:28931070 and PMID:35440735 | GALNT17 | Human | belinostat | decreases expression | EXP | | 6480464 | belinostat results in decreased expression of GALNT17 mRNA | CTD | PMID:27188386 | GALNT17 | Human | benzo[a]pyrene | decreases methylation | EXP | | 6480464 | Benzo(a)pyrene results in decreased methylation of WBSCR17 3' UTR | CTD | PMID:27901495 | GALNT17 | Human | benzo[a]pyrene | increases methylation | EXP | | 6480464 | Benzo(a)pyrene results in increased methylation of WBSCR17 promoter | CTD | PMID:27901495 | GALNT17 | Human | benzo[a]pyrene | affects methylation | EXP | | 6480464 | Benzo(a)pyrene affects the methylation of WBSCR17 intron | CTD | PMID:30157460 | GALNT17 | Human | benzo[e]pyrene | increases methylation | EXP | | 6480464 | benzo(e)pyrene results in increased methylation of WBSCR17 intron | CTD | PMID:30157460 | GALNT17 | Human | bisphenol A | decreases expression | ISO | Galnt17 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of GALNT17 mRNA | CTD | PMID:25181051 and PMID:30816183 | GALNT17 | Human | bisphenol A | increases expression | ISO | Galnt17 (Mus musculus) | 6480464 | bisphenol A results in increased expression of GALNT17 mRNA | CTD | PMID:25594700 | GALNT17 | Human | choline | multiple interactions | ISO | Galnt17 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of GALNT17 gene | CTD | PMID:20938992 | GALNT17 | Human | crocidolite asbestos | increases expression | ISO | Galnt17 (Mus musculus) | 6480464 | Asbestos and Crocidolite results in increased expression of GALNT17 mRNA | CTD | PMID:29279043 | GALNT17 | Human | cyclosporin A | decreases methylation | EXP | | 6480464 | Cyclosporine results in decreased methylation of GALNT17 promoter | CTD | PMID:27989131 | GALNT17 | Human | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GALNT17 mRNA | CTD | PMID:27188386 | GALNT17 | Human | doxorubicin | decreases expression | EXP | | 6480464 | Doxorubicin results in decreased expression of GALNT17 mRNA | CTD | PMID:29803840 | GALNT17 | Human | ethanol | affects expression | ISO | Galnt17 (Mus musculus) | 6480464 | Ethanol affects the expression of WBSCR17 mRNA | CTD | PMID:30319688 | GALNT17 | Human | folic acid | multiple interactions | ISO | Galnt17 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of GALNT17 gene | CTD | PMID:20938992 | GALNT17 | Human | folic acid | decreases expression | ISO | Galnt17 (Mus musculus) | 6480464 | Folic Acid results in decreased expression of WBSCR17 mRNA | CTD | PMID:25629700 | GALNT17 | Human | gentamycin | decreases expression | ISO | Galnt17 (Rattus norvegicus) | 6480464 | Gentamicins results in decreased expression of GALNT17 mRNA | CTD | PMID:33387578 | GALNT17 | Human | hexane | decreases methylation | ISO | Galnt17 (Rattus norvegicus) | 6480464 | n-hexane results in decreased methylation of GALNT17 promoter | CTD | PMID:23740543 | GALNT17 | Human | L-methionine | multiple interactions | ISO | Galnt17 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of GALNT17 gene | CTD | PMID:20938992 | GALNT17 | Human | lead(0) | affects expression | EXP | | 6480464 | Lead affects the expression of GALNT17 mRNA | CTD | PMID:28903495 | GALNT17 | Human | methapyrilene | increases methylation | EXP | | 6480464 | Methapyrilene results in increased methylation of WBSCR17 intron | CTD | PMID:30157460 | GALNT17 | Human | N,N-diethyl-m-toluamide | multiple interactions | ISO | Galnt17 (Rattus norvegicus) | 6480464 | [Permethrin co-treated with DEET] results in decreased methylation of GALNT17 gene | CTD | PMID:33148267 | GALNT17 | Human | PCB138 | multiple interactions | ISO | Galnt17 (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | GALNT17 | Human | perfluorohexanesulfonic acid | decreases expression | ISO | Galnt17 (Mus musculus) | 6480464 | perfluorohexanesulfonic acid results in decreased expression of GALNT17 mRNA | CTD | PMID:37995155 | GALNT17 | Human | permethrin | multiple interactions | ISO | Galnt17 (Rattus norvegicus) | 6480464 | [Permethrin co-treated with DEET] results in decreased methylation of GALNT17 gene | CTD | PMID:33148267 | GALNT17 | Human | pioglitazone | multiple interactions | ISO | Galnt17 (Mus musculus) | 6480464 | [N-nitroso-tris-chloroethylurea co-treated with Pioglitazone] results in decreased expression of GALNT17 mRNA | CTD | PMID:27935865 | GALNT17 | Human | potassium dichromate | decreases expression | ISO | Galnt17 (Mus musculus) | 6480464 | Potassium Dichromate results in decreased expression of GALNT17 mRNA | CTD | PMID:23608068 | GALNT17 | Human | resveratrol | multiple interactions | EXP | | 6480464 | [Plant Extracts co-treated with Resveratrol] results in decreased expression of GALNT17 mRNA | CTD | PMID:23557933 | GALNT17 | Human | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GALNT17 mRNA | CTD | PMID:27188386 | GALNT17 | Human | sodium arsenite | decreases expression | ISO | Galnt17 (Mus musculus) | 6480464 | sodium arsenite results in decreased expression of GALNT17 mRNA | CTD | PMID:37682722 | GALNT17 | Human | sunitinib | increases expression | EXP | | 6480464 | Sunitinib results in increased expression of GALNT17 mRNA | CTD | PMID:31533062 | GALNT17 | Human | titanium dioxide | decreases methylation | ISO | Galnt17 (Mus musculus) | 6480464 | titanium dioxide results in decreased methylation of WBSCR17 gene and titanium dioxide results in decreased methylation of WBSCR17 promoter | CTD | PMID:35295148 | GALNT17 | Human | trichostatin A | decreases expression | EXP | | 6480464 | trichostatin A results in decreased expression of GALNT17 mRNA | CTD | PMID:24935251 | GALNT17 | Human | triclosan | increases expression | EXP | | 6480464 | Triclosan results in increased expression of GALNT17 mRNA | CTD | PMID:30510588 | GALNT17 | Human | valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of GALNT17 mRNA | CTD | PMID:23179753 and PMID:26272509 | GALNT17 | Human | valproic acid | increases methylation | EXP | | 6480464 | Valproic Acid results in increased methylation of GALNT17 gene | CTD | PMID:29154799 | GALNT17 | Human | valproic acid | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GALNT17 mRNA | CTD | PMID:27188386 | GALNT17 | Human | vinclozolin | decreases expression | ISO | Galnt17 (Rattus norvegicus) | 6480464 | vinclozolin results in decreased expression of GALNT17 mRNA | CTD | PMID:23555832 | |